|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-adrenoceptors and basal limb vascular tone in healthy men
Previous studies have demonstrated that post-junctional1- and
2-adrenoceptors mediate vasoconstriction in the human forearm. However, the relative contributions of the
-adrenoceptor subtypes to basal limb vascular tone are unknown. In healthy young men, forearm blood flow (FBF; venous occlusion plethysmography) responses to brachial artery administration of prazosin (an
1-adrenoceptor antagonist), yohimbine (an
2-adrenoceptor antagonist) and phentolamine (a non-selective
-adrenoceptor antagonist) were determined after local
-adrenoceptor blockade with propranolol. In 10 subjects, prazosin increased FBF from 2.4 ± 0.3 to 5.8 ± 1.0 ml (100 ml)-1 min-1 (~140 %; P < 0.001 vs. baseline). Subsequently, phentolamine further increased FBF to 11.7 ± 1.6 ml (100 ml)-1 min-1 (~ 385 %; P < 0.001 vs. baseline). Thus, the average calculated increase in FBF due to removal of
2-vasoconstrictor tone was greater than that due to removal of
1-tone (5.9 ± 0.8 vs. 3.4 ± 0.8 ml (100 ml)-1 min-1; P < 0.01) and represented ~ 63 % of basal sympathetic tone. Complete
1-adrenoceptor blockade was confirmed by a minimal reduction in FBF in response to phenylephrine after prazosin (46 ± 3 vs. 6 ± 4 %; before vs. after blockade) and in a separate group of four subjects, increasing the dose of prazosin threefold did not evoke further forearm vasodilatation. Additionally, the reduction in FBF in response to tryamine (evokes endogenous noradrenaline release) was abolished after phentolamine (40 ± 3 vs. 2 ± 1 %; before vs. after blockade), documenting complete pharmacological sympathectomy. In another group of seven subjects, administering yohimbine prior to phentolamine resulted in similar findings. These observations indicate that vasoconstricting post-junctional
2-adrenoceptors contribute more to basal vascular tone than
1-adrenoceptors in the forearms of young healthy men. The potential physiological and pathophysiological implications of these findings are discussed.
This article has been cited by other articles:
![]() |
D. W. Wray, S. K. Nishiyama, R. A. Harris, and R. S. Richardson Angiotensin II in the Elderly: Impact of Angiotensin II Type 1 Receptor Sensitivity on Peripheral Hemodynamics Hypertension, June 1, 2008; 51(6): 1611 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Coney and J. M. Marshall Contribution of {alpha}2-adrenoceptors and Y1 neuropeptide Y receptors to the blunting of sympathetic vasoconstriction induced by systemic hypoxia in the rat J. Physiol., August 1, 2007; 582(3): 1349 - 1359. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Brothers, M. L. Haslund, D. W. Wray, P. B. Raven, and M. Sander Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle J. Physiol., December 1, 2006; 577(2): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Wilkins, W. G. Schrage, Z. Liu, K. C. Hancock, and M. J. Joyner Systemic hypoxia and vasoconstrictor responsiveness in exercising human muscle J Appl Physiol, November 1, 2006; 101(5): 1343 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuki, J. H. Eisenach, F. A. Dinenno, and M. J. Joyner Reduced forearm {alpha}1-adrenergic vasoconstriction is associated with enhanced heart rate fluctuations in humans J Appl Physiol, March 1, 2006; 100(3): 792 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Masuki, F. A. Dinenno, M. J. Joyner, and J. H. Eisenach Selective {alpha}2-adrenergic properties of dexmedetomidine over clonidine in the human forearm J Appl Physiol, August 1, 2005; 99(2): 587 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Lambert and G. D Thomas {alpha}-Adrenoceptor constrictor responses and their modulation in slow-twitch and fast-twitch mouse skeletal muscle J. Physiol., March 15, 2005; 563(3): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Rongen, W. J.G. Oyen, B. P. Ramakers, N. P. Riksen, O. C. Boerman, N. Steinmetz, and P. Smits Annexin A5 Scintigraphy of Forearm as a Novel In Vivo Model of Skeletal Muscle Preconditioning in Humans Circulation, January 18, 2005; 111(2): 173 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Dinenno and M. J. Joyner Combined NO and PG inhibition augments {alpha}-adrenergic vasoconstriction in contracting human skeletal muscle Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2576 - H2584. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Thomas and S. S. Segal Neural control of muscle blood flow during exercise J Appl Physiol, August 1, 2004; 97(2): 731 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Wray, P. J. Fadel, M. L. Smith, P. Raven, and M. Sander Inhibition of {alpha}-adrenergic vasoconstriction in exercising human thigh muscles J. Physiol., March 1, 2004; 555(2): 545 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muszkat, G. G. Sofowora, A. J.J. Wood, and C. M. Stein Alpha2-Adrenergic Receptor-Induced Vascular Constriction in Blacks and Whites Hypertension, January 1, 2004; 43(1): 31 - 35. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |